Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy: Safety and oncologic outcomes

Trang K. Nguyen, Mazen S. Zenati, Brian A. Boone, Jennifer Steve, Melissa E. Hogg, David L. Bartlett, Herbert J. Zeh, Amer H. Zureikat

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Hepatic arterial anomalies (HAAs) are not infrequently encountered during pancreatic resections. In view of the current emergence of the robotic platform as a safe alternative to open surgery in experienced centres, this study sought to determine the implications of HAAs on the safety and oncologic outcomes of robotic pancreaticoduodenectomy (RPD). Methods A prospectively maintained database of patients with HAAs who underwent RPD (RPD + HAA) at a single institution between 2008 and 2013 was retrospectively reviewed. Demographic information and perioperative outcomes of RPD were compared for patients with and without HAAs. Results A total of 142 patients underwent RPD; 112 (78.9%) did not have and 30 (21.1%) did have HAAs. The majority (90.0%) of RPDs in patients with HAAs were performed for malignant indications and all aberrant vessels were preserved without conversion to laparotomy. There were no statistically significant differences between RPD patients with and without HAAs with respect to preoperative demographics, tumour characteristics, operative metrics (operative time, estimated blood loss, conversion) and postoperative outcomes, including complications, length of stay and readmissions. Negative margin (R0) rates were similar in both groups. Conclusions Robot-assisted pancreaticoduodenectomy is safe and feasible in patients with HAAs and has outcomes similar to those in patients with normal arterial anatomy.

Original languageEnglish (US)
Pages (from-to)594-599
Number of pages6
JournalHPB
Volume17
Issue number7
DOIs
StatePublished - Jul 1 2015
Externally publishedYes

Fingerprint

Pancreaticoduodenectomy
Robotics
Anatomy
Safety
Liver
Demography
Postoperative Hemorrhage
Operative Time
Laparotomy
Length of Stay
Databases

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Nguyen, T. K., Zenati, M. S., Boone, B. A., Steve, J., Hogg, M. E., Bartlett, D. L., ... Zureikat, A. H. (2015). Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy: Safety and oncologic outcomes. HPB, 17(7), 594-599. https://doi.org/10.1111/hpb.12414

Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy : Safety and oncologic outcomes. / Nguyen, Trang K.; Zenati, Mazen S.; Boone, Brian A.; Steve, Jennifer; Hogg, Melissa E.; Bartlett, David L.; Zeh, Herbert J.; Zureikat, Amer H.

In: HPB, Vol. 17, No. 7, 01.07.2015, p. 594-599.

Research output: Contribution to journalArticle

Nguyen, TK, Zenati, MS, Boone, BA, Steve, J, Hogg, ME, Bartlett, DL, Zeh, HJ & Zureikat, AH 2015, 'Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy: Safety and oncologic outcomes', HPB, vol. 17, no. 7, pp. 594-599. https://doi.org/10.1111/hpb.12414
Nguyen, Trang K. ; Zenati, Mazen S. ; Boone, Brian A. ; Steve, Jennifer ; Hogg, Melissa E. ; Bartlett, David L. ; Zeh, Herbert J. ; Zureikat, Amer H. / Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy : Safety and oncologic outcomes. In: HPB. 2015 ; Vol. 17, No. 7. pp. 594-599.
@article{422d08ffe8c247b28d06c681a749382f,
title = "Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy: Safety and oncologic outcomes",
abstract = "Background Hepatic arterial anomalies (HAAs) are not infrequently encountered during pancreatic resections. In view of the current emergence of the robotic platform as a safe alternative to open surgery in experienced centres, this study sought to determine the implications of HAAs on the safety and oncologic outcomes of robotic pancreaticoduodenectomy (RPD). Methods A prospectively maintained database of patients with HAAs who underwent RPD (RPD + HAA) at a single institution between 2008 and 2013 was retrospectively reviewed. Demographic information and perioperative outcomes of RPD were compared for patients with and without HAAs. Results A total of 142 patients underwent RPD; 112 (78.9{\%}) did not have and 30 (21.1{\%}) did have HAAs. The majority (90.0{\%}) of RPDs in patients with HAAs were performed for malignant indications and all aberrant vessels were preserved without conversion to laparotomy. There were no statistically significant differences between RPD patients with and without HAAs with respect to preoperative demographics, tumour characteristics, operative metrics (operative time, estimated blood loss, conversion) and postoperative outcomes, including complications, length of stay and readmissions. Negative margin (R0) rates were similar in both groups. Conclusions Robot-assisted pancreaticoduodenectomy is safe and feasible in patients with HAAs and has outcomes similar to those in patients with normal arterial anatomy.",
author = "Nguyen, {Trang K.} and Zenati, {Mazen S.} and Boone, {Brian A.} and Jennifer Steve and Hogg, {Melissa E.} and Bartlett, {David L.} and Zeh, {Herbert J.} and Zureikat, {Amer H.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/hpb.12414",
language = "English (US)",
volume = "17",
pages = "594--599",
journal = "HPB",
issn = "1365-182X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy

T2 - Safety and oncologic outcomes

AU - Nguyen, Trang K.

AU - Zenati, Mazen S.

AU - Boone, Brian A.

AU - Steve, Jennifer

AU - Hogg, Melissa E.

AU - Bartlett, David L.

AU - Zeh, Herbert J.

AU - Zureikat, Amer H.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Hepatic arterial anomalies (HAAs) are not infrequently encountered during pancreatic resections. In view of the current emergence of the robotic platform as a safe alternative to open surgery in experienced centres, this study sought to determine the implications of HAAs on the safety and oncologic outcomes of robotic pancreaticoduodenectomy (RPD). Methods A prospectively maintained database of patients with HAAs who underwent RPD (RPD + HAA) at a single institution between 2008 and 2013 was retrospectively reviewed. Demographic information and perioperative outcomes of RPD were compared for patients with and without HAAs. Results A total of 142 patients underwent RPD; 112 (78.9%) did not have and 30 (21.1%) did have HAAs. The majority (90.0%) of RPDs in patients with HAAs were performed for malignant indications and all aberrant vessels were preserved without conversion to laparotomy. There were no statistically significant differences between RPD patients with and without HAAs with respect to preoperative demographics, tumour characteristics, operative metrics (operative time, estimated blood loss, conversion) and postoperative outcomes, including complications, length of stay and readmissions. Negative margin (R0) rates were similar in both groups. Conclusions Robot-assisted pancreaticoduodenectomy is safe and feasible in patients with HAAs and has outcomes similar to those in patients with normal arterial anatomy.

AB - Background Hepatic arterial anomalies (HAAs) are not infrequently encountered during pancreatic resections. In view of the current emergence of the robotic platform as a safe alternative to open surgery in experienced centres, this study sought to determine the implications of HAAs on the safety and oncologic outcomes of robotic pancreaticoduodenectomy (RPD). Methods A prospectively maintained database of patients with HAAs who underwent RPD (RPD + HAA) at a single institution between 2008 and 2013 was retrospectively reviewed. Demographic information and perioperative outcomes of RPD were compared for patients with and without HAAs. Results A total of 142 patients underwent RPD; 112 (78.9%) did not have and 30 (21.1%) did have HAAs. The majority (90.0%) of RPDs in patients with HAAs were performed for malignant indications and all aberrant vessels were preserved without conversion to laparotomy. There were no statistically significant differences between RPD patients with and without HAAs with respect to preoperative demographics, tumour characteristics, operative metrics (operative time, estimated blood loss, conversion) and postoperative outcomes, including complications, length of stay and readmissions. Negative margin (R0) rates were similar in both groups. Conclusions Robot-assisted pancreaticoduodenectomy is safe and feasible in patients with HAAs and has outcomes similar to those in patients with normal arterial anatomy.

UR - http://www.scopus.com/inward/record.url?scp=84930757001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930757001&partnerID=8YFLogxK

U2 - 10.1111/hpb.12414

DO - 10.1111/hpb.12414

M3 - Article

C2 - 25913696

AN - SCOPUS:84930757001

VL - 17

SP - 594

EP - 599

JO - HPB

JF - HPB

SN - 1365-182X

IS - 7

ER -